-
-
- Highlights
- Financial Review
- Corporate
Governance - Board of Directors
- Matters Requiring Board Approval
- Training for Directors
- Board Composition & Balance
- Independent Members of Board of Directors
- Board Committees
- Criteria for Board Membership
- Access to Information
- Remuneration Matters
- Accountability & Audit
- Internal Controls
- Internal Audit
- Communication with Shareholders
- Best Practices Guide - Dealing in Securities
-
-
-
-
INVESTORS
STOCK TRACK
MESSAGE FROM OUR CHAIRMAN
MR RICHARD SEOW
"Strong industry fundamentals, paired with a clear growth strategy, will propel ParkwayHealth to a greater leadership role in defining private sector health care in Asia."
"The future of private healthcare in Asia holds significant promise and ParkwayHealth continues to position itself to be the leading provider of value based integrated healthcare in the region."
MESSAGE FROM OUR MANAGING DIRECTOR
DR LIM CHEOK PENG
"We also achieved strong EBITDAR1 growth across all divisions. EBITDAR for Singapore Hospitals climbed 11% to S$114.7 million. EBITDAR for International Hospitals was up 32% to S$28.1 million (proforma) while Healthcare Services division rose 78% to S$49.6 million (proforma)."
"Internationally, there are now 15 hospitals under ParkwayHealth's stable and we have been able to realize efficiencies and synergies that produce results."
1 Variance over last year is computed based on proforma Revenue and EDITBAR which is computed as if the Group had adopted proportionate consolidated of Pantai's results since 1 January 2006.
RECENT UPDATES
